Wright Medical boosts foot and ankle footprint with BioMimetic buy

11/20/2012 | American City Business Journals

Wright Medical has agreed to acquire BioMimetic Therapeutics for $190 million upfront, plus as much as $190 million in payments contingent on the performance of BioMimetic's Augment bone graft tool. The deal, set to be finalized during the first quarter of next year, in part will allow Wright Medical to substantially expand its foot and ankle business, CEO Robert Palmisano said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA